(PR1J) Amundi Prime Japan DR (D) - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU1931974775 • Japan Large-Cap Equity
PR1J: Japanese Large-Cap Equities, Blue-Chip Stocks
Amundi Prime Japan UCITS ETF DR (D), traded under the ticker symbol PR1J on XETRA, is a Germany-domiciled ETF designed to provide exposure to large-cap equities in Japan. It tracks the Morningstar Japan Total Market Index, which includes a diverse range of Japanese companies across various sectors, offering a broad representation of the countrys economy. The ETF is structured under the UCITS framework, a popular regulatory regime in Europe known for its investor protections and transparency.
The ETF currently has an average daily volume of 12,155 shares over the past 20 days, with a last price of 26.49. From a technical perspective, it is trading slightly below its 20-day simple moving average (SMA) of 26.81 but above its 200-day SMA of 27.77, signaling a potential bullish trend. The 50-day SMA stands at 27.94. The Average True Range (ATR) of 0.61 reflects moderate volatility. With assets under management (AUM) of 177.46 billion EUR, the fund is well-capitalized, indicating strong investor interest and liquidity.
3-Month Forecast: Based on the current technical and fundamental data, the ETF is expected to remain range-bound with potential for minor appreciation. The proximity of the last price to the 20-day SMA suggests a consolidative phase, while the AUM growth underscores continued investor demand. The low ATR indicates that price fluctuations are likely to remain subdued, supporting a stable outlook for the ETF over the next quarter.
Additional Sources for PR1J ETF
PR1J ETF Overview
Market Cap in USD | 200,917m |
Category | Japan Large-Cap Equity |
TER | 0.05% |
IPO / Inception | 2019-01-30 |
PR1J ETF Ratings
Growth Rating | 58.2 |
Fundamental | - |
Dividend Rating | 56.4 |
Rel. Strength | -17.8 |
Analysts | - |
Fair Price Momentum | 25.21 EUR |
Fair Price DCF | - |
PR1J Dividends
Dividend Yield 12m | 1.95% |
Yield on Cost 5y | 2.97% |
Annual Growth 5y | 5.58% |
Payout Consistency | 97.7% |
PR1J Growth Ratios
Growth Correlation 3m | -79.4% |
Growth Correlation 12m | 49.4% |
Growth Correlation 5y | 77.8% |
CAGR 5y | 8.72% |
CAGR/Max DD 5y | 0.47 |
Sharpe Ratio 12m | 0.23 |
Alpha | -9.02 |
Beta | 0.789 |
Volatility | 17.11% |
Current Volume | 12.5k |
Average Volume 20d | 12.6k |
As of May 01, 2025, the stock is trading at EUR 27.65 with a total of 12,499 shares traded.
Over the past week, the price has changed by +2.28%, over one month by -0.59%, over three months by -4.74% and over the past year by +2.30%.
Partly, yes. Based on ValueRay Analyses, Amundi Prime Japan DR (D) (XETRA:PR1J) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.23 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PR1J as of May 2025 is 25.21. This means that PR1J is currently overvalued and has a potential downside of -8.82%.
Amundi Prime Japan DR (D) has no consensus analysts rating.
According to ValueRays Forecast Model, PR1J Amundi Prime Japan DR (D) will be worth about 28.6 in May 2026. The stock is currently trading at 27.65. This means that the stock has a potential upside of +3.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.6 | 3.3% |